Clinical Trial News and Research

RSS

Casdatifan demonstrates durable responses in advanced kidney cancer trial

A new multi-center clinical study is shedding light on a potential new approach for patients with advanced kidney cancer, offering measurable clinical responses alongside a clearer view into how the disease operates beneath the surface.

27 Jul 2026

Blood tests improve Alzheimer's detection in Down syndrome patients

New blood tests that detect early changes associated with Alzheimer's disease are making diagnosis easier and accessible to more patients, since they are less invasive than the brain scans or spinal taps typically used for a definitive diagnosis.

27 Jul 2026

New cancer vaccine harnesses COVID-19 immune memory to fight tumors

In a discovery that could redefine the future of cancer immunotherapy, scientists from Celloram Inc., University Hospitals and Case Western Reserve University have developed a novel cancer vaccine platform that transforms the impact of the largest immunological event in modern history – a synchronized mass immune memory generated through SARS-CoV-2 infection and vaccination – into a powerful ally against cancer.

27 Jul 2026

Phase 3 clinical trial enrolls first platinum-resistant ovarian cancer patient

The GOG Foundation, Inc. is proud to announce the enrollment of the first patient in GOG-3132/BEHOLD-Ovarian01 (NCT07286266), a global Phase 3 clinical trial titled A Randomized, Open-label, Multicenter, Phase 3 Study to Investigate Mocertatug Rezetecan Compared With Standard of Care in Participants with Platinum-resistant Ovarian Cancer.

27 Jul 2026

Primary care practices successfully deliver family-based childhood obesity treatment

Childhood obesity affects one in five children in the U.S., yet most families have limited access to specialized weight-management programs for children.

27 Jul 2026

New blood protein biomarkers estimate timing of ALS symptoms

Months to several years before amyotrophic lateral sclerosis (ALS) symptoms arise, levels of certain blood proteins may dramatically shift.

27 Jul 2026

Time-restricted eating may help lower dementia risk in older women

Results from a small clinical trial suggest it may be possible to reduce your risk of dementia by eating during fewer hours of the day.

26 Jul 2026

Photo-based calorie-tracking apps fall short in estimating meal nutrition

Thanks to advances in AI, popular calorie-tracking apps can now use a photo of a meal to estimate the nutritional content of what you're eating.

26 Jul 2026

Individualized treatment speeds recovery for babies with opioid withdrawal

A major new study shows that individualized treatment for babies born with opioid withdrawal can speed recovery and reduce time spent in the hospital.

24 Jul 2026

Oral antibiotics safely shorten hospital stays for children with pneumonia

Children hospitalized with severe pneumonia can safely switch from injectable to oral antibiotics once they begin to recover, allowing many to return home sooner and complete treatment outside hospital.

23 Jul 2026

Researchers develop artery-on-a-chip platform to predict stroke risk

Predicting an individual's risk of ischemic stroke is difficult because thrombosis embolization-the process of a blood clot detaching from the area where it formed and traveling to and then sticking in another blood vessel-is based on factors that are unique to each person.

23 Jul 2026

Proactive telehealth program helps cancer patients quit smoking

For patients diagnosed with cancer, continuing to smoke during treatment may shorten survival.

23 Jul 2026

AI-powered analytics and experimental validation: Transforming target identification in drug discovery

Discover how AI-powered analytics and experimental validation combine to improve target identification and accelerate drug discovery success.

From Axxam S.p.A 23 Jul 2026

Short-term immunosuppressive therapy briefly restores autism-like brain changes in adult mice

A new mouse study led by UCLA Health suggests that inflammation during pregnancy can trigger autism-like changes in offspring, but also that those brain and behavior effects may be rapidly but temporarily reversible in adulthood with a short-term dose of the immunosuppressive drug rapamycin.

23 Jul 2026

Spermidine boosts key cellular processes linked to aging in early research

This review finds that spermidine supports autophagy, mitochondrial function, and healthspan in experimental models, while observational studies link higher dietary intake to lower mortality. However, human trials have produced limited and mixed results, leaving its clinical role in healthy aging unresolved.

23 Jul 2026

Singing therapy provides effective relief for supragastric belching patients

A new randomized clinical trial suggests that singing therapy may provide a more effective and engaging treatment option than standard breathing exercises for people with supragastric belching, a chronic gastrointestinal disorder that can significantly affect quality of life.

22 Jul 2026

Fecal microbe capsules show promise in treating chronic insomnia

In a randomized clinical trial published in the Journal of Internal Medicine, ingesting capsules containing fecal microbes from healthy donors helped treat symptoms of insomnia.

22 Jul 2026

New ARPA-H grant aims to advance genomic medicines for rare vascular diseases

Massachusetts General Hospital, a founding member of the Mass General Brigham healthcare system, has been awarded an Advanced Research Projects Agency for Health (ARPA-H) contract to develop advanced personalized genomic medicines to treat rare genetic vascular diseases.

21 Jul 2026

Swimming can be clinically effective in reducing disability from chronic low back pain

Australian research has shown for the first time that a program of swimming can be clinically effective in reducing disability from chronic low back pain.

21 Jul 2026

City of Hope launches trial to map how tumors change during immunotherapy resistance

City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States with its National Medical Center ranked among the nation's top cancer centers by U.S. News & World Report, has opened an innovative Phase 2 clinical trial designed to map how tumors change as they begin to resist immunotherapy, treatment that improves the immune system's ability to fight disease.

21 Jul 2026